Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for l root_relationships_comments in Relationship Comments (approximate match)

Showing 41 - 50 of 89 results

First page
Previous page
Next page
Next page

VCH-286

NDX9EX5ATP

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

AZD-1092

WVG4BZB398

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

WCK-1152

WT7488BZD3

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

BC-3205

RD6BAR4875

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

TAK-779 CATION

RN3X97C29H

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

C-C chemokine receptor type 5

C-C chemokine receptor type 2

Human immunodeficiency virus 1

C-C chemokine receptor type 5

Conditions:

Focal cerebral ischemia

TAK-779 is a selective antagonist of CCR5 receptor, which was initially developed by Takeda for the treatment of HIV infection. However, the development was terminated due to poor oral bioavailability. Also, TAK-779 demonstrated the ability to protect the brain against focal cerebral ischemia in mice.

N-(E)-FERUOYL-L-TYROSINE AMIDE

79HLX9P5O6

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

FONTURACETAM, (R)-

X4X99EKB3S

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

KLB-2

VFR3BK96HV

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

KLB-1

TH6K9M9WMM

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

N-ACETYL OXCARBAZEPINE

KPX385K89N

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

Structure of VCH-286

ABSOLUTE

Structure of AZD-1092

ABSOLUTE

Structure of WCK-1152

ABSOLUTE

Structure of BC-3205

ABSOLUTE

Structure of TAK-779 CATION

ACHIRAL

Structure of N-(E)-FERUOYL-L-TYROSINE AMIDE

ABSOLUTE

N-(E)-FERUOYL-L-TYROSINE AMIDE

Structure of FONTURACETAM, (R)-

ABSOLUTE

FONTURACETAM, (R)-

Structure of KLB-2

ACHIRAL

Structure of KLB-1

ACHIRAL

Structure of N-ACETYL OXCARBAZEPINE

ACHIRAL

N-ACETYL OXCARBAZEPINE

Showing 41 - 50 of 89 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1